GTCbio Biomarker Summit Europe 2016

GTCbio would like to invite you to attend our Biomarker Summit Europe 2016 on October 5-7, 2016 in Berlin, Germany!

The summit will address the latest developments in the biomarker arena from discovery to translation to commercialization. Presentations span across multiple disciplines and cover topics such as discovery and validation strategies, the challenges of clinical translation, novel technologies including next-generation sequencing, companion diagnostics, the health economics value of biomarkers, reimbursement environment, and perspective on cell free biomarkers for disease diagnostics. Scientific data, case studies and discussions will be facilitated by key representatives from pharma, biotech, academia and the public sector.

Biomarker Summit Europe 2016 consists of four conferences including joint sessions:

Conference: 10th Biomarkers in Drug Discovery and Development
Conference: 5th Biomarkers in Diagnostics
Conference: Biomarkers in Clinical Development and Clinical Trials
Conference: Cell-Free Biomarkers

10th Biomarkers in Drug Discovery and Development
I. Biomarker Discovery and Identification Strategies
II. Biomarkers from Qualification to Validation
III. Biomarkers of Translational Medicine: Safety, PK/PD, and Efficacy
IV. Biomarkers in Personalized Medicine
V. Big Data Analytics for Biomarkers Development

5th Biomarkers in Diagnostics
I. Novel Diagnostic Technologies
II. New Diagnostic Biomarkers and Their Development
III. Companion Diagnostics Development and Commercialization
IV. Joint Session: Clinical Utility of Diagnostic and Screening Biomarkers
V. Joint Session: Health Economics Value of Biomarkers and Reimbursement Environment
VI. Joint Session: Regulatory Considerations in Clinical Dx

Biomarkers in Clinical Development and Clinical Trials
I. Joint Session: Clinical Utility of Diagnostic and Screening Biomarkers
II. Joint Session: Health Economics Value of Biomarkers and Reimbursement Environment
III. Joint Session: Regulatory Considerations in Clinical Dx
IV. Clinical Trials and Developments
V. Biomarkers and Surrogate Endpoints for Clinical Trials

Cell-Free Biomarkers
I. Circulating Biomarkers Overview
II. Cell-free DNA and RNA Technologies and Their Platforms
III. Clinical Applications of Cell-Free DNA and RNA in Disease Diagnosis and Management
IV. New Developments in Cell-Free Biomarkers
V. Exosomes in Diagnosis, Treatment, and Disease Management